What is the ticker symbol for Ascendis Pharma A/S?

Ascendis Pharma A/S trades under the ticker ASND on NASDAQ.

What sector does Ascendis Pharma A/S operate in?

Ascendis Pharma A/S is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ASND in a portfolio?

PortView shows ASND's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Ascendis Pharma A/S (ASND) Stock Analysis

NASDAQHealthcareBiotechnology

$264.84+1.76%

1-year price historyRange $189.74 – $277.18

52-week range$264.84

$186.05$282.15

What Ascendis Pharma A/S does

Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.

Key metrics

Market cap

$16.45B

P/E (TTM)

-109.44

EPS (TTM)

$-2.42

Beta

0.38

Dividend yield

0.00%

Revenue / share

$16.39

50-day avg

$256.15

200-day avg

$231.58

52-week high

$282.15

52-week low

$186.05

CEO

Jan Moller Mikkelsen

ETFs linked to ASND

Broad-market and Healthcare sector ETFs an investor holding Ascendis Pharma A/S is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ASND fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ASND in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Ascendis Pharma A/S?: Ascendis Pharma A/S trades under the ticker ASND on NASDAQ.
Which exchange is ASND listed on?: ASND is listed on NASDAQ.
What sector does Ascendis Pharma A/S operate in?: Ascendis Pharma A/S is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ASND in a portfolio?: PortView shows ASND's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.